14981
Rolapitant and netupitant are other NK1 receptor antagonists that are currently in phase III clinical trials .
 Chemical: Rolapitant; Chemical: netupitant
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: Rolapitant; Chemical: netupitant